Is NBIX a good stock to buy? We came across a bullish thesis on Neurocrine Biosciences, Inc. on TradersPro’s Substack. In this article, we will summarize the bulls’ thesis on NBIX. Neurocrine Biosciences, Inc.’s share was trading at $159.76 as of June 12th. NBIX’s trailing and forward P/E were 24.58 and 22.57 respectively according to Yahoo Finance.
Likoper/Shutterstock.com
Neurocrine Biosciences, Inc. (NBIX) is a San Diego-based biopharmaceutical company focused on central nervous...
